LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

LONDON (AFX) - AIM-listed Provexis said it has entered into an exclusive
12-month agreement with an unnamed, global branded food group to jointly develop
and use Provexis' Fruitflow bioactive food ingredient, which has been shown to
combat thrombosis.
The company, which develops scientifically-proven functional and medical
foods, said the agreement will see the two groups jointly developing a
second-generation concentrated format of Fruitflow to increase the scope of its
applications.
Provexis described the agreement as "an important milestone" and noted it
hopes to establish a "long-term, global licensing deal" with the partner food
group within 12 months.
Meanwhile, Provexis also announced the resignation, with immediate effect,
of chief executive Stephen Franklin.
Stephen Moon, up until now the company's commercial director, has been
appointed as Franklin's replacement.
Franklin will continue to work at Provexis as acting director of research
until early 2007, the company said.
newsdesk@afxnews.com

Is this partner PEPSI ? cos this news was out 20 days back, if it is refering to PEPSICO then we are looking at 10P or higher soon.

http://www.advfn.com/news_Provexis_16228014.html

this is very old news..maybe even a year. PXS is already in a provisional agreement with Unilever which is what the above refers to. This is for development of second generation additive which is more usable in a wider range of products. The unilever deal excludes use in juices and drinks as well aas DVT related products. So the Pepsico rumour is an additional tie up which was also expected, the recent statement saying they are in discussions with two ( as well as Unilever) global brands....

From today's timesonline....

Tiddler to watch

Shares in Provexis, the food sciences company, rose 23 per cent to 4p, suggesting that it may be close to signing a licensing deal for its products. Last week Provexis said that it was scrapping its Sirco juice brand to negotiate exclusive rights for licensing partners. Provexiss products may help to deal with blood-clotting and can go into dairy or juice drinks

5p breached ! what next ?

4.75p !

next level is 6.2p followed by 8p and 12p or alteast thats what I read from the charts

Cool! bring it on !

Big news, change in directorship, New director from rubicon group, with experience in mergers and aquisitions.

PXS mean business then...

with yerterdays selling i guess short timers and some profit takers are out so hope we can march ahead again. 8p fingers crossed

3.75p to buy following recent market fall, good level to buy now

Chat on iii board suggests that an announcement is due by the end of this month.

Also, tipped in "Shares" magazine this week:-

http://www.sharesmagazine.com/node/1227

SAS Rue la Boetie
Credit Agricole SA
Calyon SA
Credit Agricole Cheuvreux SA 15,000,000 3.74%

it's clear that there is not much interest here for this share. I guess when news eventually arrives there will be a rush of interest lol, good 17% rise today and expectations rather than fact. Too many people have bene very patient with this one but it will come good.

Hi Global Nomad - I've been watching this one, too, and was pleased to see the shift yesterday. I'm convinced that contracts for Fruitflow will flow eventually, so am holding on to my shares.

Large volume today.

Announcement believed to be imminent.

I'll believe it when I see it !

I'll continue to hold but it's very tedious waiting around for the "good news"

I've been hanging around for ages on this one, and in the end sold as I got bored. However, today's Press Roundup has this from The Times: "Word of a tie-up between Provexis and Coca-Cola".

I think it's time to buy some again, while it's still quiet out there.

Yes, this from the Times this am... it all sounds rather laboured and drawn out and is based on evaluations at this stage..but... it's better than nothing !

AIM-listed Provexis, the developer of functional foods, held steady at 4.125p, despite word of a tie-up with Coca-Cola. The company is expected to confirm that the Atlanta-based soft drinks giant is evaluating the potential use of Fruitflow, Provexiss patented tomato extract, which it claims helps to thin the blood. Unilever is currently assessing the use of Fruitflow in dairy products.

Thanks Skyhigh - I'd not seen the details. I'm sure we'll get there eventually - have bought some this morning but didn't have a lot of spare cash as it's tied up elsewhere, waiting for profits...